{"protocolSection": {"identificationModule": {"nctId": "NCT00461812", "orgStudyIdInfo": {"id": "NA_00001154"}, "organization": {"fullName": "Johns Hopkins University", "class": "OTHER"}, "briefTitle": "A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma", "officialTitle": "A Single-Blind, Randomized, Positive-controlled Study to Compare Monotherapy With an Inhaled Corticosteroid (Mometasone) to Combination Therapy With an Inhaled Corticosteroid + a Long-Acting Bronchodilator (Advair) in Patients With Milder Persistent Asthma"}, "statusModule": {"statusVerifiedDate": "2017-09", "overallStatus": "TERMINATED", "whyStopped": "by sponsor due to failure to recruit patients who had mild persistent asthma who were not already on Advair 250/50 or 500/50.", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-04", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2010-01-19", "type": "ACTUAL"}, "completionDateStruct": {"date": "2010-01-19", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-04-16", "studyFirstSubmitQcDate": "2007-04-16", "studyFirstPostDateStruct": {"date": "2007-04-18", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2017-08-14", "resultsFirstSubmitQcDate": "2017-09-19", "resultsFirstPostDateStruct": {"date": "2017-09-20", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2017-09-19", "lastUpdatePostDateStruct": {"date": "2017-09-20", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Johns Hopkins University", "class": "OTHER"}, "collaborators": [{"name": "Schering-Plough", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The research hypothesis for the proposed study asks the question, can Asmanex\u00ae demonstrate comparable anti-inflammatory therapeutic efficacy to the combination product, Advair\u00ae in control of mild persistent asthma?\n\nThe purpose is to demonstrate that the anti-inflammatory protection afforded by monotherapy with an inhaled steroid (Asmanex\u00ae) is comparable to combination therapy with Advair\u00ae 100/50, when measured by this standard methodology (methacholine bronchoprovocation) in subjects with mild persistent asthma."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "SINGLE"}}, "enrollmentInfo": {"count": 33, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Mometasone", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Mometasone"]}, {"label": "Advair", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Advair"]}], "interventions": [{"type": "DRUG", "name": "Mometasone", "armGroupLabels": ["Mometasone"]}, {"type": "DRUG", "name": "Advair", "armGroupLabels": ["Advair"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Efficacy as Assessed my Pulmonary Function Tests", "timeFrame": "change from baseline to study completion"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* subjects 18 to 65 years of age\n* a \\>2 year history of asthma\n* FEV1 \\> 80% for subjects currently using Advair\u00ae.\n\nExclusion Criteria:\n\n* severe asthma\n* current smokers\n* pregnant or breast-feeding women\n* other chronic significant illnesses", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Peter S Creticos, MD", "affiliation": "Johns Hopkins University", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Johns Hopkins Asthma and Allergy Center", "city": "Baltimore", "state": "Maryland", "zip": "21224", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "33 participants were consented for this study. However, there were 23 pre-randomization screening failures. Only 10 were enrolled. The number of participants assigned/randomized to each Arm/Group is unknown.", "groups": [{"id": "FG000", "title": "All Participants", "description": "Mometasone\n\nor\n\nAdvair"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}], "dropWithdraws": [{"type": "study terminated", "reasons": [{"groupId": "FG000", "numSubjects": "10"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "The number of participants assigned/randomized to each Arm/Group is unknown", "groups": [{"id": "BG000", "title": "All Participants", "description": "Mometasone\n\nor\n\nAdvair"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "10"}]}], "measures": [{"title": "Age, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": ">=18, <=16 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "6"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "4"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Efficacy as Assessed my Pulmonary Function Tests", "populationDescription": "There is no data available for this outcome measure. The study was prematurely terminated and the PI is no longer with the institution. The information available was obtained from the IRB.", "reportingStatus": "POSTED", "timeFrame": "change from baseline to study completion", "groups": [{"id": "OG000", "title": "Mometasone", "description": "Mometasone"}, {"id": "OG001", "title": "Advair", "description": "Advair"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "description": "There is no data available for adverse events. The study was prematurely terminated and the PI is no longer with the institution. The information available was obtained from the IRB.", "eventGroups": [{"id": "EG000", "title": "All Participants", "description": "Mometasone\n\nor\n\nAdvair\n\nAdverse event data and the number of participants assigned to each Arm/Group is unknown because the PI left the institution and this information is unavailable", "deathsNumAffected": 0, "deathsNumAtRisk": 0, "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 0, "otherNumAtRisk": 0}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Johns Hopkins University Clinical Trials Program", "organization": "Johns Hopkins University School of Medicine", "email": "registerclinicaltrials@jhmi.edu", "phone": "410-550-6484"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068656", "term": "Mometasone Furoate"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}], "browseLeaves": [{"id": "M290", "name": "Mometasone Furoate", "asFound": "At 3", "relevance": "HIGH"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M249", "name": "Fluticasone-Salmeterol Drug Combination", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}]}}, "hasResults": true}